https://www.openbell.ai/ 2026-09-28T11:58:36.621Z hourly 1.0 https://www.openbell.ai/support 2026-09-28T11:58:36.621Z monthly 0.7 https://www.openbell.ai/privacy 2026-09-28T11:58:36.621Z monthly 0.5 https://www.openbell.ai/terms 2026-09-28T11:58:36.621Z monthly 0.5 https://www.openbell.ai/feed.json 2026-09-28T11:58:36.621Z hourly 0.8 https://www.openbell.ai/news/AGEN:1790596713633 2026-09-28T11:58:33.633Z daily 0.9 https://cdn.brandfetch.io/AGEN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Rodman &amp; Renshaw Initiates Coverage On Agenus with Buy Rating, Announces Price Target of $19 Rodman & Renshaw analyst Michael King has initiated coverage on Agenus (NASDAQ: AGEN) with a Buy rating. The firm has set a price target of $19 for the company's stock. https://www.openbell.ai/news/AMPX:1790596594319 2026-09-28T11:56:34.319Z daily 0.9 https://cdn.brandfetch.io/AMPX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Amprius Technologies shares are trading higher after the company announced it secured a $75 million grant for American high-energy density battery production. openbell Financial News https://www.openbell.ai/news/JKHY:1790596549141 2026-09-28T11:55:49.141Z daily 0.9 https://cdn.brandfetch.io/JKHY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Seaport Global Initiates Coverage On Jack Henry &amp; Associates with Buy Rating, Announces Price Target of $193 Seaport Global analyst Jeff Cantwell has initiated coverage on Jack Henry & Associates (NASDAQ: JKHY) with a Buy rating. The analyst has set a price target of $193 for the company's stock. https://www.openbell.ai/news/MU:1790596482316 2026-09-28T11:54:42.316Z daily 0.9 https://cdn.brandfetch.io/MU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Baird Maintains Outperform on Micron Technology, Raises Price Target to $1520 Baird analyst Tristan Gerra has maintained an 'Outperform' rating on Micron Technology (NASDAQ: MU) and raised the price target from $1280 to $1520. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/BHVN:1790596184742 2026-09-28T11:49:44.742Z daily 0.9 https://cdn.brandfetch.io/BHVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Biohaven To Present Data On BHV-1530, FGFR3-Directed ADC Using Topoisomerase I Payload, At 38th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics Biohaven Ltd. announced that data on its FGFR3-directed antibody-drug conjugate, BHV-1530, will be presented at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics from November 18-20, 2026. The Phase 1 findings from the ongoing BHV1530-101 study indicate early clinical activity and a favorable safety profile, with no dose-limiting toxicities reported. Additionally, Biohaven has begun enrolling patients for a study evaluating BHV-1530 in combination with Regeneron's cemiplimab (Libtayo). https://www.openbell.ai/news/KOD:1790596054859 2026-09-28T11:47:34.859Z daily 0.9 https://cdn.brandfetch.io/KOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kodiak Sciences shares are trading higher after the company announced that the primary endpoints were met for Zenkuda and tabirafusp-ted in the Phase 3 DAYBREAK study in patients with wet age-related macular degeneration. openbell Financial News https://www.openbell.ai/news/AMPX:1790595948494 2026-09-28T11:45:48.494Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/A-Soldier-In-Camouflage-Observes-A-Drone.jpg?width=250&height=187 Amprius Lands $75 Million Defense Grant to Supercharge US Drone Battery Production Amprius Technologies, Inc. secured a grant of up to $75 million from the U.S. Department of Defense to convert an existing electric vehicle battery production line into a facility for high-energy-density battery cells for drones. The project, expected to cost around $100 million and completed by early 2028, will have an annual production capacity of approximately 12 million cells. In its recent financial report, Amprius reported quarterly revenue of $34.03 million, exceeding analyst estimates, and anticipates fiscal 2026 revenue above $140 million. https://www.openbell.ai/news/TSX:SGR:1790595871214 2026-09-28T11:44:31.214Z daily 0.9 https://cdn.brandfetch.io/TSX:SGR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brixmor Property Group And Everview Partners To Acquire Slate Grocery REIT For $13 Per Share In Cash At An EV Of ~$2.3B Slate Grocery REIT has entered into a definitive agreement with Brixmor Property Group and Everview Partners to be acquired for $13 per share in cash, totaling an enterprise value of approximately $2.3 billion. This transaction represents a premium of about 13% over the closing price prior to the announcement and is expected to close in the first quarter of 2027, pending Unitholder and court approvals. The deal follows a strategic review process and includes a termination of the existing management agreement with a $50 million payment to the manager. https://www.openbell.ai/news/COIN:1790595546151 2026-09-28T11:39:06.151Z daily 0.9 https://cdn.brandfetch.io/COIN/w/400/h/400?c=1idopYfmtR7ZKg8QMud &#39;Citi Expands Digital-Assets Footprint With Coinbase Partnership&#39; - WSJ Exclusive Citi has announced a partnership with Coinbase to enhance its digital-assets offerings, marking a significant expansion in its footprint within the cryptocurrency sector. This collaboration aims to provide clients with access to digital asset services, reflecting the growing interest in cryptocurrencies among institutional investors. The partnership is expected to strengthen Citi's position in the rapidly evolving digital finance landscape. https://www.openbell.ai/news/VLY:1790595364213 2026-09-28T11:36:04.213Z daily 0.9 https://cdn.brandfetch.io/VLY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Valley To Acquire Bluevine For ~$340M Valley National Bancorp (NASDAQ: VLY) has entered into a definitive agreement to acquire Bluevine Inc. for approximately $340 million, comprising 75% cash and 25% Valley common stock. The acquisition aims to enhance Valley's funding base and expand its small business franchise, adding $2.1 billion of low-cost deposits and a digital banking platform serving around 175,000 small business customers. The deal is expected to be 8% accretive to estimated 2028 earnings per share, though it will result in about 5% tangible book value dilution at closing, with a projected earn back period of three years. https://www.openbell.ai/news/MTEK:1790595357894 2026-09-28T11:35:57.894Z daily 0.9 https://cdn.brandfetch.io/MTEK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Maris-Tech Announces $10M Order For Airborne Defense Video Systems Under Project With Magam Safety; Options Could Lift Total To About $14.1M openbell Financial News https://www.openbell.ai/news/PVLA:1790595301452 2026-09-28T11:35:01.452Z daily 0.9 https://cdn.brandfetch.io/PVLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Palvella Therapeutics Receives Third Year Of Grant Funding From FDA Office Of Orphan Products Development For Phase 3 SELVA Trial And Ongoing Open-Label Extension Study Of QTORIN 3.9% Rapamycin Anhydrous Gel For Treatment Of Microcystic Lymphatic Malformations Palvella Therapeutics has received its third year of grant funding from the FDA's Office of Orphan Products Development for its Phase 3 SELVA trial and ongoing open-label extension study of QTORIN 3.9% rapamycin anhydrous gel, aimed at treating microcystic lymphatic malformations. The Phase 3 SELVA trial recently reported positive topline results, achieving all primary and secondary efficacy endpoints with statistical significance (p<0.001). This trial was one of only seven selected for funding out of 51 applications in fiscal year 2024, marking it as the only Phase 3 trial to receive a grant that year. https://www.openbell.ai/news/GLND:1790595240768 2026-09-28T11:34:00.768Z daily 0.9 https://cdn.brandfetch.io/GLND/w/400/h/400?c=1idopYfmtR7ZKg8QMud Greenland Energy Completes 2026 Environmental Baseline Field Program At Jameson Land Project In East Greenland Greenland Energy Company (NASDAQ: GLND) has successfully completed its 2026 environmental baseline field program at the Jameson Land Project in East Greenland, advancing the permitting process for exploration drilling. The program, approved by Greenland's Ministry of Business and Mineral Resources, involved collecting soil and freshwater samples, conducting vegetation studies, and monitoring wildlife activity. This work builds on previous environmental assessments and supports the ongoing Environmental Impact Assessment (EIA). https://www.openbell.ai/news/METC:1790595210110 2026-09-28T11:33:30.110Z daily 0.9 https://cdn.brandfetch.io/METC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Ramaco Resources Awarded $30M In Damages From Federal Jury In Insurance Lawsuit Against Federal Insurance company, ACE American Insurance Company Ramaco Resources, Inc. announced that a federal jury awarded $30 million in damages to its subsidiary, Ramaco Resources, LLC, in an insurance coverage lawsuit against Federal Insurance Company and ACE American Insurance Company, both part of Chubb Insurance. The verdict was reached in the United States District Court for the Southern District of West Virginia. https://www.openbell.ai/news/QUCY:1790595209814 2026-09-28T11:33:29.814Z daily 0.9 https://cdn.brandfetch.io/QUCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Quantum Cyber Files Audited Financials For Arcade Acquisition, Discloses $4.18M All-Cash Purchase Price With No Assumed Debt openbell Financial News https://www.openbell.ai/news/SNOW:1790595185375 2026-09-28T11:33:05.375Z daily 0.9 https://cdn.brandfetch.io/SNOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Snowflake shares are trading lower after the company announced a proposed private placement of $3.5 billion of 0.00% Convertible Senior Notes. openbell Financial News https://www.openbell.ai/news/IMRX:1790595153251 2026-09-28T11:32:33.251Z daily 0.9 https://cdn.brandfetch.io/IMRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Immuneering Says Atebimetinib Patients Held Weight At About Twice Benchmark Rate, Linked To Longer Pancreatic Cancer Survival openbell Financial News https://www.openbell.ai/news/SCYX:1790595081150 2026-09-28T11:31:21.150Z daily 0.9 https://cdn.brandfetch.io/SCYX/w/400/h/400?c=1idopYfmtR7ZKg8QMud SCYNEXIS Announces $214M BARDA Contract For Antifungal SCY-247, With About $18.5M In Initial Funding openbell Financial News https://www.openbell.ai/news/C:1790594866592 2026-09-28T11:27:46.592Z daily 0.9 https://cdn.brandfetch.io/C/w/400/h/400?c=1idopYfmtR7ZKg8QMud &#39;Citigroup to Arrange $1 Billion US-Backed Debt Swap for Kenya&#39; - Bloomberg Citigroup is set to arrange a $1 billion debt swap for Kenya, backed by the United States. This strategic move aims to assist Kenya in managing its debt obligations more effectively. The arrangement is expected to have significant implications for Kenya's financial stability and may influence investor sentiment in the region. https://www.openbell.ai/news/USO:1790594826077 2026-09-28T11:27:06.077Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud &#39;Saudi Arabia’s Crucial Oil Pipeline Starts Exports After Repairs&#39; - Bloomberg Saudi Arabia has resumed exports through a key oil pipeline following recent repairs. This development is significant for the global oil market as the pipeline plays a crucial role in the country's oil supply chain. The restoration of operations is expected to stabilize oil prices and enhance Saudi Arabia's export capacity. https://www.openbell.ai/news/HUT:1790594553445 2026-09-28T11:22:33.445Z daily 0.9 https://cdn.brandfetch.io/HUT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Hut 8 Closes $1.07B 4-Yr Senior Secured Revolving Credit Facility Hut 8 Corp. has closed a $1.07 billion four-year senior secured revolving credit facility, enhancing its liquidity and capital access as it aims for an investment-grade corporate profile. This facility allows for immediate access to non-dilutive capital with a drawn margin of SOFR plus 150 to 200 basis points, and it supports collateral requirements for site development, improving capital efficiency. The financing builds on Hut 8's previous $7.5 billion in investment-grade project financing for its AI data center campuses. https://www.openbell.ai/news/META:1790594441452 2026-09-28T11:20:41.452Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Mark-Zuckerberg-Speaks-At-Georgetown-Uni.jpg?width=250&height=187 Why Meta’s 13% Stock Gain Last Week Could Be Just the Start — Gene Munster Sees $11 Billion Revenue Opportunity That Could ‘Blow Us Away’ Meta Platforms Inc. (NASDAQ: META) experienced a 12.90% stock increase over the past week, attributed to the potential of personalized artificial intelligence products like Muse. Analyst Gene Munster estimates that if 5% of Meta's 3.6 billion daily users subscribe at $5 per month, it could generate $11 billion in annual revenue, while a more aggressive scenario could yield $108 billion. Currently, META's stock is up 13.87% year-to-date and closed at $225.07, though it was down 3.04% in overnight trading. https://www.openbell.ai/news/SES:1790594174971 2026-09-28T11:16:14.971Z daily 0.9 https://cdn.brandfetch.io/SES/w/400/h/400?c=1idopYfmtR7ZKg8QMud SES AI’s Battery Manufacturing Facility In Chungju, South Korea Secures ISO 9001:2015 Certification For Quality Management System SES AI Corporation has achieved ISO 9001:2015 certification for its battery manufacturing facility in Chungju, South Korea, enhancing its quality management system as it aims for an annual production capacity of approximately one million cells. The certification was granted by the Korea ESG Certification Body after an independent assessment. Additionally, recent changes in South Korean export control standards for secondary batteries are expected to provide SES AI with competitive advantages in exporting its NDAA-compliant pouch cells. https://www.openbell.ai/news/DPRO:1790594146354 2026-09-28T11:15:46.354Z daily 0.9 https://cdn.brandfetch.io/DPRO/w/400/h/400?c=1idopYfmtR7ZKg8QMud EXCLUSIVE: Draganfly Secures $10M Strategic Investment from Unusual Machines And A US Investment Fund of $5M Each To Support and Expand Drone Manufacturing; Investment Offering Was Made for 1.869M Shares At $5.35/Share openbell Financial News https://www.openbell.ai/news/DPRO:1790594126750 2026-09-28T11:15:26.750Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Munich--Bavaria--Germany---March-31-2023.jpg?width=250&height=187 EXCLUSIVE: Draganfly Secures $10 Million Strategic Capital to Scale Drone Manufacturing Draganfly Inc. (NASDAQ: DPRO) has secured $10 million in strategic capital from Unusual Machines Inc. (NYSE: UMAC) and a leading U.S. investment fund, with each contributing $5 million. The funds will be used to enhance drone manufacturing capabilities and support growth in commercial and defense sectors, particularly in the U.S. and Canada. The investment involves a registered direct offering of 1,869,159 shares priced at $5.35 each, with the transaction expected to close around September 30, 2026. https://www.openbell.ai/news/BLSM:1790593941996 2026-09-28T11:12:21.996Z daily 0.9 https://cdn.brandfetch.io/BLSM/w/400/h/400?c=1idopYfmtR7ZKg8QMud BlossomHill Therapeutics Presents Preclinical Data On BH-501284 At AACR Conference On Pancreatic Cancer; Targets IND Filing In Q1 2027 BlossomHill Therapeutics presented preclinical data on its KRAS inhibitor, BH-501284, at the AACR Conference on Pancreatic Cancer, demonstrating prolonged target engagement and potent antitumor activity in multiple KRAS-mutant cancer models. The company plans to submit an Investigational New Drug (IND) application for BH-501284 in Q1 2027. This novel compound is designed to provide improved efficacy and tolerability compared to existing KRAS-targeted therapies. https://www.openbell.ai/news/TLSA:1790593791780 2026-09-28T11:09:51.780Z daily 0.9 https://cdn.brandfetch.io/TLSA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tiziana Life Sciences Says First Three Participants Receive First Dose Of Intranasal Foralumab In Phase 2a Healey ALS Mymatch BANYAN Clinical Trial Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) announced that the first three participants have received their initial dose of intranasal foralumab in the Phase 2a Healey ALS MyMatch BANYAN clinical trial. This trial aims to evaluate the efficacy of intranasal foralumab in individuals with amyotrophic lateral sclerosis (ALS) and is co-funded by the ALS Association. The study will take place at multiple locations, including the Healey & AMG Center in Boston and other sites in Chicago, Minneapolis, and Davie. https://www.openbell.ai/news/ACIW:1790593753539 2026-09-28T11:09:13.539Z daily 0.9 https://cdn.brandfetch.io/ACIW/w/400/h/400?c=1idopYfmtR7ZKg8QMud ACI Worldwide And Cognizant Say BASE24-eps Card Software Ran Over Double Target Load On AWS In Testing With No Failures openbell Financial News https://www.openbell.ai/news/BRX:1790593683873 2026-09-28T11:08:03.873Z daily 0.9 https://cdn.brandfetch.io/BRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Brixmor And Everview Announce $2.34B Deal To Acquire Slate Grocery REIT, With Brixmor Taking 23 Centers For $636M openbell Financial News https://www.openbell.ai/news/MBRX:1790593589242 2026-09-28T11:06:29.242Z daily 0.9 https://cdn.brandfetch.io/MBRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Moleculin Announces Publication Of 90-Patient Pooled Analysis Showing No Heart Toxicity With Annamycin, Including Above Standard Dose Limits openbell Financial News https://www.openbell.ai/news/KNDI:1790593536332 2026-09-28T11:05:36.332Z daily 0.9 https://cdn.brandfetch.io/KNDI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kandi Technologies Announces Second Order For Heavy-Truck Battery Swap Stations From CATL&#39;s QIJI Energy; Terms Not Disclosed openbell Financial News https://www.openbell.ai/news/NVDA:1790593475621 2026-09-28T11:04:35.621Z daily 0.9 https://cdn.brandfetch.io/NVDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nvidia Announces $150B Increase To Buyback Program, Bringing Remaining Authorization To $235B Through FY2028 openbell Financial News https://www.openbell.ai/news/REZI:1790593448580 2026-09-28T11:04:08.580Z daily 0.9 https://cdn.brandfetch.io/REZI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Evercore ISI Group Initiates Coverage On Resideo Technologies with Outperform Rating, Announces Price Target of $30 Evercore ISI Group has initiated coverage on Resideo Technologies (NYSE: REZI) with an 'Outperform' rating. The firm has set a price target of $30 for the company's stock. https://www.openbell.ai/news/ARVN:1790593391521 2026-09-28T11:03:11.521Z daily 0.9 https://cdn.brandfetch.io/ARVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Arvinas Announces First Patient Dosed In Phase 1/2 Trial Of ARV-6723 In Advanced Solid Tumors openbell Financial News https://www.openbell.ai/news/ANTX:1790593364922 2026-09-28T11:02:44.922Z daily 0.9 https://cdn.brandfetch.io/ANTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud AN2 Therapeutics Announces Gates Foundation Funding Extension For Tuberculosis Research Collaboration With GSK openbell Financial News https://www.openbell.ai/news/KNDI:1790593307722 2026-09-28T11:01:47.722Z daily 0.9 https://cdn.brandfetch.io/KNDI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kandi Technologies Gr H1 EPS $0.10 Up From $0.02 YoY, Sales $57.117M Up From $36.291M YoY Kandi Technologies Group (NASDAQ: KNDI) reported a first-half earnings per share (EPS) of $0.10, a 400% increase from $0.02 in the same period last year. The company's sales reached $57.117 million, marking a 57.39% increase compared to $36.291 million in the previous year. https://www.openbell.ai/news/NIQ:1790592652887 2026-09-28T10:50:52.887Z daily 0.9 https://cdn.brandfetch.io/NIQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud NielsenIQ Launches Amazon Third-Party Marketplace Measurement For All Health &amp; Beauty Care Categories NielsenIQ has launched a new measurement tool for Amazon's third-party marketplace specifically for the Health & Beauty Care categories, integrating this data with existing retail measurements. This initiative addresses a significant measurement gap, as third-party sellers on Amazon generated approximately $56 billion in Health and Beauty sales, accounting for 24% of tracked omnichannel category sales in the U.S. The new offering aims to provide brands with insights into consumer behavior and emerging market trends, enhancing their competitive positioning and innovation strategies. This launch is part of NIQ's broader 'Full View' strategy and is now accessible via the NIQ Discover platform. https://www.openbell.ai/news/ACET:1790592586153 2026-09-28T10:49:46.153Z daily 0.9 https://cdn.brandfetch.io/ACET/w/400/h/400?c=1idopYfmtR7ZKg8QMud Adicet Bio Announces Safety And Efficacy Data From Phase 1 Study Evaluating Prulacabtagene Leucel In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis; Prula-Cel Generally Well Tolerated With No CRS Greater Than Grade 2 And No IEC-HS Or ICANS Adicet Bio reported that in a Phase 1 study of Prulacabtagene Leucel for systemic lupus erythematosus, 54% of evaluable patients achieved DORIS remission and 50% achieved complete response rates at 12 months. The treatment was generally well tolerated, with no cases of cytokine release syndrome greater than Grade 2. The company plans to initiate pivotal trial activities for lupus nephritis in Q4 2026, potentially expanding the study to include lupus without nephritis due to the high remission rates observed. https://www.openbell.ai/news/GLD:1790592141323 2026-09-28T10:42:21.323Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Image-Of-Gold-Bullion-And-Gold-Coins.jpg?width=250&height=187 Gold Bull Run Looks Finished—Unless You Look Closer Gold prices have fallen sharply, with a 3.35% decline marking the steepest drop since early June, attributed to a shift in interest-rate sentiment towards a more hawkish stance. Analysts suggest that profit-taking by Chinese investors ahead of the Golden Week holiday contributed to the selling pressure. The decline may lead to a retest of yearly lows, with the Relative Strength Index indicating further downside potential. Despite short-term challenges, some analysts believe the structural case for gold remains intact due to ongoing central bank buying and concerns over U.S. government debt. https://www.openbell.ai/news/TFX:1790592009183 2026-09-28T10:40:09.183Z daily 0.9 https://cdn.brandfetch.io/TFX/w/400/h/400?c=1idopYfmtR7ZKg8QMud B of A Securities Upgrades Teleflex to Buy, Raises Price Target to $158 B of A Securities has upgraded Teleflex (NYSE: TFX) from Neutral to Buy, with the price target increased from $145 to $158. Analyst Craig Bijou made this adjustment, reflecting a positive outlook for the company's stock. https://www.openbell.ai/news/LXRX:1790591986943 2026-09-28T10:39:46.943Z daily 0.9 https://cdn.brandfetch.io/LXRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Cantor Fitzgerald Initiates Coverage On Lexicon Pharmaceuticals with Overweight Rating, Announces Price Target of $8 Cantor Fitzgerald analyst Steve Seedhouse has initiated coverage on Lexicon Pharmaceuticals (NASDAQ: LXRX) with an Overweight rating. The firm has set a price target of $8 for the company's stock. https://www.openbell.ai/news/BAK:1790591763244 2026-09-28T10:36:03.244Z daily 0.9 https://cdn.brandfetch.io/BAK/w/400/h/400?c=1idopYfmtR7ZKg8QMud HSBC Downgrades Braskem to Hold, Lowers Price Target to $1.5 HSBC analyst Sriharsha Pappu has downgraded Braskem (NYSE: BAK) from a Buy rating to Hold. The price target for the stock has been significantly reduced from $6.5 to $1.5. https://www.openbell.ai/news/SRFM:1790591741593 2026-09-28T10:35:41.593Z daily 0.9 https://cdn.brandfetch.io/SRFM/w/400/h/400?c=1idopYfmtR7ZKg8QMud Surf Air Mobility Signs MoU With The FAA To Participate In The Agency’s Strategic Management Of Airspace, Routes, And Trajectories Program Surf Air Mobility has signed a Memorandum of Understanding (MoU) with the FAA to participate as a Participating Airspace User in the FAA’s SMART program, which aims to modernize air traffic management. The company will contribute operational data and expertise from its experience with Southern Airways and Mokulele Airlines, leveraging its AI-powered SurfOS. This initiative aligns with Surf Air Mobility's strategic goals of advancing air mobility and commercializing electric passenger flights, while focusing on profitability across its business lines. https://www.openbell.ai/news/NVDA:1790591690627 2026-09-28T10:34:50.627Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/28/Nvidia.jpg?width=250&height=187 Nvidia Unveils AI Safety Platform to Keep AI Agents Under Control, Partners With Anthropic Nvidia Corp. has launched a new AI safety platform designed to prevent AI agents from breaching containment, featuring Nvidia OpenShell and Sentry tools for enhanced monitoring. The platform is partly open source and aims to encourage partners like Cisco, Microsoft, and Oracle to develop related products. Additionally, Nvidia is collaborating with Anthropic to integrate cloud-managed agents with OpenShell, emphasizing the need for improved safety measures in AI development. https://www.openbell.ai/news/KOD:1790591652563 2026-09-28T10:34:12.563Z daily 0.9 https://cdn.brandfetch.io/KOD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kodiak Sciences Says Phase 3 DAYBREAK Study Met Primary Endpoints With Zenkuda (Tarcocimab Tedromer) And Tabirafusp-ted (KSI-501) Showing Non-inferiority In Vision Gains For Wet Age-related Macular Degeneration Vs. Aflibercept At Year One Kodiak Sciences announced that its Phase 3 DAYBREAK study for Zenkuda (tarcocimab tedromer) and Tabirafusp-ted (KSI-501) met primary endpoints, showing non-inferiority in vision gains for wet age-related macular degeneration compared to aflibercept. Zenkuda achieved a p-value of 0.0007, with 54% of patients benefiting from 6-month dosing, while Tabirafusp-ted had a p-value of 0.0036 for vision gains. A biologics license application for Zenkuda is planned for Q4 2026, and post-hoc analyses for treatment-naïve patients are forthcoming. Both treatments demonstrated a safety profile consistent with aflibercept. https://www.openbell.ai/news/IONQ:1790591576659 2026-09-28T10:32:56.659Z daily 0.9 https://cdn.brandfetch.io/IONQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud B of A Securities Initiates Coverage On IonQ with Buy Rating, Announces Price Target of $60 B of A Securities analyst Vivek Arya has initiated coverage on IonQ (NYSE: IONQ) with a Buy rating. The firm has set a price target of $60 for the company's stock. https://www.openbell.ai/news/BUDA:1790591399132 2026-09-28T10:29:59.132Z daily 0.9 https://cdn.brandfetch.io/BUDA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Roth Capital Initiates Coverage On Buda Juice with Buy Rating, Announces Price Target of $12 Roth Capital analyst George Kelly has initiated coverage on Buda Juice (AMEX: BUDA) with a Buy rating. The firm has set a price target of $12 for the stock. https://www.openbell.ai/news/INCY:1790591325316 2026-09-28T10:28:45.316Z daily 0.9 https://cdn.brandfetch.io/INCY/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright &amp; Co. Maintains Buy on Incyte, Raises Price Target to $152 HC Wainwright & Co. analyst Mitchell S. Kapoor has maintained a Buy rating on Incyte (NASDAQ: INCY) and increased the price target from $150 to $152. https://www.openbell.ai/news/NU:1790591136672 2026-09-28T10:25:36.672Z daily 0.9 https://cdn.brandfetch.io/NU/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Reiterates Buy on Nu Holdings, Maintains $19 Price Target Needham analyst Kyle Peterson has reiterated a Buy rating on Nu Holdings (NYSE: NU) and maintained a price target of $19 for the stock. This endorsement reflects confidence in the company's performance and potential for growth. https://www.openbell.ai/news/RHP:1790590973560 2026-09-28T10:22:53.560Z daily 0.9 https://cdn.brandfetch.io/RHP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Raymond James Maintains Outperform on Ryman Hospitality Props, Raises Price Target to $130 Raymond James analyst RJ Milligan has maintained an 'Outperform' rating on Ryman Hospitality Properties (NYSE: RHP) and raised the price target from $125 to $130.